Caroline C Øhrstrøm1,2, Dorte Worm3, Urd Lynge Kielgast4, Jens Juul Holst5, Dorte L Hansen6. 1. Department of Medicine, Zealand University Hospital, Lykkebækvej 1, 4600, Køge, Denmark. carolinechristfort@hotmail.com. 2. Steno Diabetes Center Copenhagen, Gentofte, Denmark. carolinechristfort@hotmail.com. 3. Department of Medicine, Amager Hospital, Copenhagen, Denmark. 4. Department of Medicine, Zealand University Hospital, Lykkebækvej 1, 4600, Køge, Denmark. 5. Department of Biomedical Sciences and Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark. 6. Steno Diabetes Center Copenhagen, Gentofte, Denmark.
Abstract
BACKGROUND: Early dumping and post-bariatric hypoglycemia (PBH) are often addressed as two separate postprandial complications after Roux-en-Y gastric bypass (RYGB). The aim of the study was to evaluate the occurrence of early dumping in RYGB-operated individuals with PBH with and without treatment intervention. METHODS:Eleven RYGB-operated women with documented PBH each underwent abaseline liquid mixed meal test (MMT) followed by five MMTs preceded by treatment with: acarbose 50 mg for 1 week, sitagliptin 100 mg for 1 week, verapamil 120 mg for 1 week, liraglutide 1.2 mg for 3 weeks, and pasireotide 300 μg as a single dose. Repetitive venous blood sampling and continuous electrocardiogram recordings were performed at fasting and during a 3-h postprandial period. RESULTS: During the baseline MMT, there was a significant increase in HR (from 65 ± 2 to 90 ± 4 bpm, p < 0.0001) within 30 min after meal intake, while hypoglycemia occurred in the later postprandial period. The HR increase was accompanied by significant increases in serum albumin, plasma norepinephrine, blood glucose, serum insulin, and plasma GLP-1 concentrations. The postprandial HR changes were positively correlated with the changes in insulin and GLP-1 concentrations. Treatment with acarbose and pasireotide both reduced HR, plasma norepinephrine, and serum insulin, and pasireotide also decreased plasma GLP-1. CONCLUSIONS: RYGB-operated individuals with PBH also have large early postprandial HR increases, hemoconcentration, and sympathetic activation, consistent with early dumping. Moreover, hormone excursions associated with PBH appear to be related to measures of early dumping, suggesting a causal relationship between early dumping and PBH. TRIAL REGISTRATION: NCT02527993.
RCT Entities:
BACKGROUND: Early dumping and post-bariatric hypoglycemia (PBH) are often addressed as two separate postprandial complications after Roux-en-Y gastric bypass (RYGB). The aim of the study was to evaluate the occurrence of early dumping in RYGB-operated individuals with PBH with and without treatment intervention. METHODS: Eleven RYGB-operated women with documented PBH each underwent a baseline liquid mixed meal test (MMT) followed by five MMTs preceded by treatment with: acarbose 50 mg for 1 week, sitagliptin 100 mg for 1 week, verapamil 120 mg for 1 week, liraglutide 1.2 mg for 3 weeks, and pasireotide 300 μg as a single dose. Repetitive venous blood sampling and continuous electrocardiogram recordings were performed at fasting and during a 3-h postprandial period. RESULTS: During the baseline MMT, there was a significant increase in HR (from 65 ± 2 to 90 ± 4 bpm, p < 0.0001) within 30 min after meal intake, while hypoglycemia occurred in the later postprandial period. The HR increase was accompanied by significant increases in serum albumin, plasma norepinephrine, blood glucose, serum insulin, and plasma GLP-1 concentrations. The postprandial HR changes were positively correlated with the changes in insulin and GLP-1 concentrations. Treatment with acarbose and pasireotide both reduced HR, plasma norepinephrine, and serum insulin, and pasireotide also decreased plasma GLP-1. CONCLUSIONS: RYGB-operated individuals with PBH also have large early postprandial HR increases, hemoconcentration, and sympathetic activation, consistent with early dumping. Moreover, hormone excursions associated with PBH appear to be related to measures of early dumping, suggesting a causal relationship between early dumping and PBH. TRIAL REGISTRATION: NCT02527993.
Authors: Nam Q Nguyen; Tamara L Debreceni; Carly M Burgstad; Judith M Wishart; Max Bellon; Chris K Rayner; Gary A Wittert; Michael Horowitz Journal: Obes Surg Date: 2015-08 Impact factor: 4.129
Authors: A B Goldfine; E C Mun; E Devine; R Bernier; M Baz-Hecht; D B Jones; B E Schneider; J J Holst; M E Patti Journal: J Clin Endocrinol Metab Date: 2007-09-25 Impact factor: 5.958
Authors: George Tharakan; Preeshila Behary; Nicolai J Wewer Albrechtsen; Harvinder Chahal; Julia Kenkre; Alexander D Miras; Ahmed R Ahmed; Jens J Holst; Stephen R Bloom; Tricia Tan Journal: Eur J Endocrinol Date: 2017-08-30 Impact factor: 6.664